JRSIS HEALTH CARE Corp financial data

Symbol
JRSS on OTC
Industry
Services-Hospitals
Location
3/F Building A, Derun Yuan, No. 19 Changyi Road, Changmingshui, Wuguishan, Zhongshan City, China
State of incorporation
FL
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Dec 20, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 79.9 % -47.1%
Quick Ratio 18.3 %
Debt-to-equity -114 % -184%
Return On Equity 15.4 % -99.8%
Return On Assets -23.2 % -101%
Operating Margin -19.5 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 84.6M shares
Common Stock, Shares, Outstanding 84.6M shares +1349%
Entity Public Float 5.63M USD +616%
Common Stock, Value, Issued 8.46K USD +1351%
Weighted Average Number of Shares Outstanding, Basic 84.6M shares +10.2%
Weighted Average Number of Shares Outstanding, Diluted 84.6M shares +10.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 3.47M USD -55.2%
Cost of Revenue 3.03M USD -48%
Research and Development Expense 133K USD -20.3%
Selling and Marketing Expense 436K USD +932%
General and Administrative Expense 548K USD +332%
Operating Income (Loss) -676K USD -68.3%
Nonoperating Income (Expense) 107K USD -17.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -569K USD -37.3%
Income Tax Expense (Benefit) 7 USD
Net Income (Loss) Attributable to Parent -490K USD -101%
Earnings Per Share, Basic -0.01 USD/shares -100%
Earnings Per Share, Diluted -0.01 USD/shares -100%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 33.4K USD +201%
Accounts Receivable, after Allowance for Credit Loss, Current 575K USD
Inventory, Net 362K USD
Assets, Current 1.79M USD +239%
Property, Plant and Equipment, Net 46.2K USD
Operating Lease, Right-of-Use Asset 874 USD
Intangible Assets, Net (Excluding Goodwill) 241K USD
Assets 2.07M USD +267%
Accounts Payable, Current 8K USD 0%
Employee-related Liabilities, Current 1.17K USD -22%
Accrued Liabilities, Current 75.6K USD
Contract with Customer, Liability, Current 55.5K USD
Liabilities, Current 2.3M USD +2429%
Liabilities 2.31M USD +2436%
Accumulated Other Comprehensive Income (Loss), Net of Tax 143K USD +1101%
Retained Earnings (Accumulated Deficit) -3.88M USD +83.9%
Stockholders' Equity Attributable to Parent -198K USD -142%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -234K USD -149%
Liabilities and Equity 2.07M USD +267%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -205K USD -1142%
Net Cash Provided by (Used in) Financing Activities 413K USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 84.6M shares +1349%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 205K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.37K USD +85.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 11.9K USD -28.2%
Deferred Tax Assets, Valuation Allowance 4.88M USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.25 pure 0%
Operating Lease, Liability 1.82K USD
Depreciation 11.8K USD -29.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -492K USD -696%
Lessee, Operating Lease, Liability, to be Paid 1.82K USD -83.1%
Property, Plant and Equipment, Gross 150K USD
Operating Lease, Liability, Current 1.82K USD -83.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.82K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) 4.61K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 12 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 10.7K USD +628%
Preferred Stock, Shares Authorized 2M shares 0%
Additional Paid in Capital 3.53M USD -85.6%
Amortization of Intangible Assets 37K USD +3.82%
Depreciation, Depletion and Amortization -874K USD -99.8%
Interest Expense 11.9K USD -39.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%